In vivo delayed-type hypersensitivity in 109 patients with vitiligo

International Journal of Dermatology

Volumn 39, Issue 8, 2000, Pages 593-598

  Behrens Williams, S C ^a   Peters, E M ^a   Schallreuter, K U ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; THYROID ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; AUTOIMMUNITY; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; SKIN; SKIN PIGMENTATION; SKIN TEST; VITILIGO;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; MALE; MIDDLE AGED; SKIN TESTS; VITILIGO;

EID: 0033811451     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2000.00011.x     Document Type: Conference Paper

References (39)

1. Vitiligo: Where do we stand?
2. Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo
3. T cell profiles in vitiligo
4. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance
5. Cell-mediated autoimmune diseases of the skin: Some hypotheses
6. Vitiligo: It is important
7. Evidence for immunologic mechanisms in human vitiligo: Patient's sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity
8. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo
9. Immunological adjuvance of metabolic origin: Oxidative stress, postulated impaired function of thiol proteases and immunogenicity
10. '7-Tetrahydrobiopterin', a naturally occurring analogue of tetrahydrobiopterin, is a cofactor for and a potential inhibitor of the aromatic amino acid hydroxylases
11. Increased sensitivity to peroxidative agents as a possible pathogenetic factor of melanocyte damage in vitiligo
12. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin
13. The cytotoxicity of 6-biopterin to human melanocytes
14. Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo
15. Increased monoamine oxidase A activity in the epidermis of patients with vitiligo
16. Photomedicine
17. Thyroid antibodies in northern Norway: Prevalence, persistence and relevance
18. Prevalence of thyroid antibodies among healthy middle-aged women. Findings from the thyroid study in healthy women
19. Peripheral T-cell subset imbalance in patients with vitiligo and in their apparently healthy first-degree relatives
20. Aberrations in T lymphocytes and natural killer cells in vitiligo: A flow cytometric study
21. T cell subpopulations in vitiligo: A chronobiologic study
22. Vitiligo: Peripheral T-cell subset imbalance as defined by monoclonal antibodies
23. Standardized cutaneous testing with recall antigens in patients with malignant melanoma, atopic dermatitis and healthy controls
24. Reduced in vivo cell-mediated immune responses to mumps, tuberculin, and streptokinase/streptodornase but not to Candida albicans in oral lichen planus
25. Impaired delayed type cutaneous hypersensitivity in rheumatoid arthritis reversed by chryotherapy
26. Impaired cell-mediated immunity of apparently normal patients who had multiple skin cancers
27. In vivo delayed-type hypersensitivity skin test anergy in human immunodeficiency virus type I infection is associated with T cell nonresponsiveness in vitro
28. Multitest CMI for standardized measurement of delayed cutaneous hypersensitivity and cell-mediated immunity. Normal values and proposed scoring system for healthy adults in the USA
29. Specific immune responses to skin test antigens following repeated multiple antigen skin tests in normal individuals
30. Cell-mediated immunity assessed by skin testing (Multitest). Normal values in healthy Danish adults
31. Measurement of delayed cutaneous hypersensitivity by the Multitest system
32. A standardized method measuring delayed cutaneous hypersensitivity: Its interest for detection of the risks related to impaired immune competence
33. Delayed-type hypersensitivity skin testing: Normal values in the Australian population
34. T and B lymphocytes in vitiligo
35. Possible functional impairment of Langerhans' cells in vitiliginous skin
36. Diminished contact sensitivity response in vitiliginous skin
37. Low catalase levels in the epidermis of patients with vitiligo
38. Serum selenium levels and blood glutathione peroxidase activities in vitiligo